Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 01 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-0.45 Insider Own91.38% Shs Outstand25.63M Perf Week5.80%
Market Cap60.74M Forward P/E- EPS next Y-0.55 Insider Trans0.00% Shs Float2.21M Perf Month7.83%
Income-11.60M PEG- EPS next Q-0.11 Inst Own27.51% Short Float / Ratio0.11% / 0.13 Perf Quarter-15.05%
Sales0.00M P/S- EPS this Y6.13% Inst Trans49.08% Short Interest0.00M Perf Half Y-6.32%
Book/sh0.33 P/B7.29 EPS next Y-23.65% ROA-80.39% Target Price6.50 Perf Year24.74%
Cash/sh0.33 P/C7.13 EPS next 5Y- ROE-84.53% 52W Range1.62 - 4.05 Perf YTD-2.22%
Dividend- P/FCF- EPS past 5Y- ROI-139.25% 52W High-41.48% Beta-1.15
Dividend %- Quick Ratio12.63 Sales past 5Y0.00% Gross Margin- 52W Low46.30% ATR0.23
Employees2 Current Ratio12.63 Sales Q/Q- Oper. Margin0.00% RSI (14)54.32 Volatility7.83% 8.29%
OptionableNo Debt/Eq0.00 EPS Q/Q13.18% Profit Margin- Rel Volume0.13 Prev Close2.28
ShortableYes LT Debt/Eq0.00 EarningsNov 14 AMC Payout- Avg Volume19.23K Price2.37
Recom1.00 SMA2010.16% SMA50-6.07% SMA200-10.39% Volume2,548 Change3.95%
Nov-14-23 04:05PM
Oct-19-23 09:40AM
Oct-06-23 04:06PM
Oct-03-23 09:40AM
10:06AM Loading…
Sep-21-23 10:06AM
Sep-20-23 04:29PM
Aug-30-23 08:00AM
Aug-22-23 09:37AM
Aug-21-23 08:00AM
Aug-15-23 10:20AM
Jun-12-23 09:40AM
May-30-23 08:33AM
May-24-23 09:40AM
May-19-23 09:35AM
08:00AM Loading…
May-11-23 08:00AM
Mar-28-23 08:00AM
Mar-08-23 08:00AM
Feb-14-23 09:30AM
Feb-10-23 08:38AM
Jan-09-23 08:00AM
Dec-21-22 05:42AM
Nov-10-22 08:00AM
Nov-01-22 04:00PM
Sep-26-22 08:56AM
Sep-20-22 08:00AM
Sep-09-22 08:00AM
Aug-23-22 05:00PM
03:00PM Loading…
Aug-16-22 03:00PM
Jul-14-22 06:23AM
Jul-05-22 07:57AM
Jun-23-22 04:00PM
May-24-22 04:00PM
May-11-22 09:00AM
Apr-01-22 07:00AM
Feb-11-22 08:00AM
Feb-04-22 04:30AM
Jan-06-22 07:00AM
Jan-04-22 07:00AM
Jan-03-22 07:00AM
Nov-12-21 08:00AM
Oct-13-21 08:00AM
Oct-12-21 08:59AM
Oct-05-21 08:00AM
Sep-27-21 07:41AM
Sep-22-21 04:05PM
Sep-20-21 08:13AM
Sep-13-21 08:00AM
Sep-07-21 08:00AM
Aug-23-21 08:31AM
Aug-16-21 08:39AM
Aug-12-21 08:00AM
Aug-09-21 08:01AM
Aug-08-21 03:23AM
Aug-03-21 02:40PM
Jul-26-21 08:02AM
Jul-12-21 08:22AM
Jun-21-21 04:05PM
May-06-21 08:00PM
Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the provision of pharmaceutical services. Its product candidate, ANEB-001, is currently in phase two of trial. The company was founded by Joseph F. Lawler on April 23, 2020 and is headquartered in Lakeway, TX.